- JP-listed companies
- Fuso Pharmaceutical Industries,Ltd.
- Income statement
Fuso Pharmaceutical Industries,Ltd.【JP:4538】Income statement
Market cap
¥22.4B
P/E ratio
8.8x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 44,320 | 48,581 | 49,098 | 47,042 | 45,752 | 46,782 | 45,900 | 46,074 | 46,902 | 49,251 | 49,632 | 51,015 | 55,407 | 60,563 |
| Cost of revenue | - | - | - | 34,046 | 33,202 | 33,532 | 32,630 | 32,644 | 34,101 | 35,142 | 36,235 | 37,275 | 41,568 | 44,030 |
| Gross profit | - | - | - | 12,995 | 12,550 | 13,249 | 13,269 | 13,429 | 12,801 | 14,109 | 13,397 | 13,740 | 13,838 | 16,532 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 796 | 296 | 656 | 798 | 1,261 | 1,010 | 2,351 | 1,924 | 2,206 | 1,964 | 4,131 |
| Operating expenses | - | - | - | 12,199 | 12,254 | 12,593 | 12,471 | 12,168 | 11,790 | 11,760 | 11,473 | 11,533 | 11,874 | 12,401 |
| Income before tax | 74 | 3,747 | 2,741 | 678 | 172 | 642 | 832 | 1,279 | 1,066 | 2,227 | 1,996 | 2,215 | 1,868 | 3,780 |
| Provision for income taxes | - | - | - | 311 | 107 | 200 | 391 | 361 | 335 | 737 | 427 | 599 | 389 | -1,682 |
| Net income | 266 | 4,871 | 1,979 | 340 | 10 | 861 | 970 | 894 | 707 | 1,607 | 1,483 | 1,605 | 1,377 | -3,288 |
| Earnings per share | 2.94 | 53.81 | 21.87 | 3.77 | 0.11 | 95.86 | 109.61 | 101.96 | 80.59 | 183.18 | 169.09 | 183.07 | 159.98 | -384.95 |
| Dividend per share | 6 | 8 | 8 | 8 | 8 | 44 | 80 | 80 | 60 | 60 | 60 | 70 | 70 | 82 |